Summary
Slices of rabbit hippocampus were preincubated with 3H-noradrenaline (3H-NA), then superfused continuously in the presence of the noradrenaline (NA) uptake inhibitor (+)oxaprotilin and twice stimulated electrically. The stimulation induced tritium overflow was increased by the 5-HT receptor agonists, 5-HT, 2-methyl-5-HT and 5-carboxamidotryptamine in a concentration dependent manner; a tyramine-like displacement of NA by the 5-HT agonists was prevented by (+)oxaprotilin. The 5-HT M-receptor antagonists, MDL 72222 and ICS 205-930, inhibited the facilitatory effects of 5-HT agonists as well as the enhanced tritium overflow due to the selective 5-HT uptake inhibitor, 6-nitroquipazine: in each case, concentrations much higher than those required to block M-receptors of the periphery were necessary. At high concentrations MDL 72222, in contrast to ICS 205-930, seems to have α-adrenoceptor antagonistic activity. The 5-HT2 receptor antagonist, ketanserin, had no effect on 5-HT-induced facilitation of transmitter release; metitepin facilitated stimulationevoked transmitter release per se both in the absence and presence of phentolamine.
From our results we conclude that, as on peripheral nerve endings, also on central noradrenergic terminals, facilitatory 5-HT receptors are present that modulate NA release. The enhanced tritium overflow following 6-nitroquipazine may be due to an increased release of endogenous 5-HT, a suggestion which supports the hypothesis of a physiological innervation of these facilitatory 5-HT receptors on NA terminals.
Similar content being viewed by others
References
Classen K, Göthert G, Schlicker E (1984) Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones in the rat brain and comparison with the effects of quipazine. Naunyn-Schmiedeberg's Arch Pharmacol 326:198–202
Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of (3H) 5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116–124
Feuerstein TJ, Hertting G, Jackisch R (1985a) Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol 107:233–242
Feuerstein TJ, Hertting G, Jackisch R (1985a) Endogenous noradrenaline as modulator of hippocampal serotin (5-HT)-release. Naunyn-Schmiedeberg's Arch Pharmacol 329:216–221
Fozard JR (1984a) MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–44
Fozard JR (1984b) Neuronal 5-HT receptors in the periphery. Neuropharmacol 23 No 12B:1473–1486
Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125
Fozard JR, Mobarok Ali ATM, Newgrosh G (1979) Blockade of serotonin receptors on automatic neurones by (−)cocaine and some related compounds. Eur J Pharmacol 59:195–210
Frankhuyzen AL, Mulder AH (1982) Pharmacological characterization of presynaptic α-adrenoceptors modulating (3H) noradrenaline and (3H)5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol 81:97–106
Galzin AM, Moret C, Langer SZ (1984) Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotoninergic nerve endings in the rat hippothalamus. J Pharmacol Exp Ther 228:725–732
Göthert M (1982) Modulation of serotonin release in the brain via presynaptic receptors. Tr Pharmacol Sci 11:437–440
Göthert M, Dührsen K (1979) Effects of 5-hydroxytryptamine and related compounds on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 308:9–18
Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 317:199–203
Hammond DL, Tyce GM, Yaksh TL (1985) Efflux of 5-hydroxytryptamine and noradrenaline into spinal cord superfusates during stimulation of the rat medulla. J Physiol 359:151–162
Hertting G, Zumstein A, Jackisch R, Hoffmann I, Starke K (1980) Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 315:111–117
Humphrey PPA (1984) Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacol 23 No 12B: 1503–1510
Jackisch R, Werle E, Hertting G (1984) Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro. Neuropharmacol 23 No 12A:1363–1371
Janssen PAJ (1983) 5-HT2 receptor blockade to study serotonin-induced pathology. Tr Pharmacol Sci 5:198–206
Lupp A, Feuerstein TJ (1986) The serotonin (5-HT) autoreceptor in the rabbit hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 332:R83
Reader TA, Gauthier P (1984) Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5–7-DHT and p-CPA. J Neur Transm 59:207–227
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Schlicker E, Göthert M, Köstermann F, Clausing R (1983) Effects of α-adrenoceptor antagonists on the release of serotonin and noradrenaline from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 323:106–113
Storm-Mathisen J (1977) Localisation of transmitter candidates in the brain: the hippocampal formation as a model. Progr Neurobiol 8:119–181
Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurons of rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:123–141
van Praag HM (1984) Studies in the mechanism of action of serotonin precursors in depression. Psychpharmacol Bull 20 No 3:599–602
Waldmeier PC, Baumann PA, Hauser K, Maitre L, Storni A (1982) Oxaprotilin, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. Biochem Pharmacol 31:2169–2176
Author information
Authors and Affiliations
Additional information
This study was supported by the Deutsche Forschungsgemeinschaft (SFB 70 and 325)
Rights and permissions
About this article
Cite this article
Feuerstein, T.J., Hertting, G. Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: Evidence for facilitatory 5-HT receptors within the CNS. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 191–197 (1986). https://doi.org/10.1007/BF00512929
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00512929